Luminex eceives FDA clearance to add new clinical targets and additional sample type
Luminex announced it has received FDA clearance to add three new targets to its xTAG® Gastrointestinal Pathogen Panel.In addition, FDA has now cleared xTAG GPP for use with specimens in Cary-Blair medium, a common transport medium for collection and preservation of microbiological specimens. September 29, 2014